Audio recording of Q2 FY27 earnings call now available

Investor Communications View source PDF Explain this filing

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+10.5%Reaction day

₹1967.30

prior close

₹2050.00

announcement price

After-mkt

timing

Nifty Smallcap 250market+2.0%+8.5% vs market

Pharmaceuticals peers, median of 173sector+0.8%+9.7% vs sector

On the reaction day the stock moved 8.5 pts more than Nifty Smallcap 250 and 9.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+6.1

10m

+6.1

15m

+2.3

30m

+4.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+10.5+2.0+8.5+0.8+9.7

Next day

+13.7+2.8+10.9+1.6+12.1

+12.3pendingpending+1.5+10.9

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Emcure Pharmaceuticals has made the audio recording of its November 3, 2026 Q2 FY27 earnings call available on its website. The filing only provides a link to the recording and does not disclose any financial results, forecasts or targets.

Likely market impact

No new financial details or confirmed targets are included, so the filing itself gives shareholders no clear signal for the stock price.